Sun Pharmaceutical Industries Ltd.
BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1847.30
12.90 (0.70%) Sun Pharmaceutical Industries submits analyst meet intimation
Date: 17-10-2023Sun Pharmaceutical Industries has informed that it enclosed press release relating to Earnings Call for financial results for the second quarter ending September 30, 2023.
The above information is a part of company’s filings submitted to BSE.